Prognostic value of vascular endothelial growth factor and its receptors Flt-1 and Flk-1 in astrocytic tumours.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 11459088.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Vascular endothelial growth factor (VEGF )/ vascular permeability factor (VPF) is an important regulator of angiogenesis and vascular permeability. We examined immunohistochemically expressions of VEGF and its corresponding receptors Flt-1 and Flk-1 in a series of 50 astrocytic tumours. and correlated their expressions with the degree of angiogenesis, brain edema and prognosis. There were significant relationships between VEGF, Flk-1 expressions and glioma malignancy grading, intratumoural vascularity and peritumoural brain edema, respectively. Patients with VEGF positive low grade astrocytoma and glioblastoma multiforme had a significantly shorter mean overall survival time than those with negative tumours (P = 0.0010 and 0.0180, respectively). Flk-1 is also a sigrificant prognostic factor within each tumour grade, which has a negative impact on overall survival. Additionally, overexpression of VEGF and Flk-1 were significantly associated with earlier recurrence in patients with low grade astrocytomas (P = 0.0018 and 0.0240, respectively). It is possible to subcategorize each grade of astrocytic tumours based on their VEGF and Flk-1 staining pattern, which may be crucial in predicting the biological behavior of tumours and thus provide useful information with regard to adequate treatment.
Medical subject headings
- Astrocytoma
- Brain Neoplasms
- Endothelial Growth Factors
- Glioblastoma
- Lymphokines
- Neovascularization, Pathologic
- Receptor Protein-Tyrosine Kinases
- Receptors, Growth Factor